Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05489601 · ClinicalTrials.gov registry record
Non-intrusive Detection of Temporary Neurologic Impairment by Opioids
A clinical trial of Neurologic Impairment by Opioids, sponsored by Zxerex Corporation.
- Completed
- Registry status
- 17
- Enrollment target
- 1
- Study location
NCT05489601 is a study of Neurologic Impairment by Opioids that has completed, run by Zxerex Corporation. The registered enrollment target is 17 participants. The trial reports 1 study location across 1 state.
The verdict
NCT05489601, a study of Neurologic Impairment by Opioids, has completed, sponsored by Zxerex Corporation.
- COMPLETED
- Registry status
- 17 participants
- Enrollment target
- 1
- Study location
Study Summary
The investigators aim to prove the feasibility of a non-invasive means to identify temporary neurological impairment resulting from the use of a commonly prescribed opioid by identifying an oculomotor biosignature associated with temporary neurologic impairment in pain-free opioid-naïve subjects, and to initiate the development of such a signature. The investigators also sought to establish the presence of a dose-dependent biosignature for opioid impairment.
Conditions Studied
Interventions
- DRUG Oxycodone
Study Locations (1)
Arizona
- Mayo Clinic - Scottsdale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2020-02-28 |
| Est. Completion | 2022-03-29 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05489601
The ClinicalTrials.gov registry entry for NCT05489601 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Zxerex Corporation, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Neurologic Impairment by Opioids appearing as the primary indexed condition, and to 1 intervention - of which Oxycodone is the first listed.
NCT05489601 reports 1 study location spanning 1 distinct geographic area - top geographies include Arizona.
Frequently Asked Questions
What is clinical trial NCT05489601 about?
NCT05489601 is a clinical study titled "Non-intrusive Detection of Temporary Neurologic Impairment by Opioids". The investigators aim to prove the feasibility of a non-invasive means to identify temporary neurological impairment resulting from the use of a commonly prescribed opioid by identifying an oculomotor biosignature associated with temporary neurologic impairment in pain-free opioid-naïve subjects, a...
What is the current status of trial NCT05489601?
This trial is currently completed. The enrollment target is 17 participants. The study started on 2020-02-28. Estimated completion is 2022-03-29.
What conditions does trial NCT05489601 study?
This clinical trial studies the following conditions: Neurologic Impairment by Opioids.
What interventions are being tested in trial NCT05489601?
The interventions under investigation include: Oxycodone (DRUG).
Who is sponsoring clinical trial NCT05489601?
This trial is sponsored by Zxerex Corporation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05489601 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.